GET THE APP

..

Metabolomics:Open Access

ISSN: 2153-0769

Open Access

Citations Report

Metabolomics:Open Access : Citations & Metrics Report

Articles published in Metabolomics:Open Access have been cited by esteemed scholars and scientists all around the world.

Metabolomics:Open Access has got h-index 14, which means every article in Metabolomics:Open Access has got 14 average citations.

Following are the list of articles that have cited the articles published in Metabolomics:Open Access.

  2022 2021 2020 2019 2018

Year wise published articles

20 30 24 7 9

Year wise citations received

102 110 105 105 96
Journal total citations count 895
Journal impact factor 1.8
Journal 5 years impact factor 3.73
Journal cite score 2.25
Journal h-index 14
Journal h-index since 2018 9
Important citations

Shoheilian Khorzoghi M, Khanafari A, Hedayati M, Faam B (2014) Association of Consuming Probiotic Yoghurt Consumption with Changes in Thyroid Hormones and Weight in Male Wistar Rats. Iranian Journal of Endocrinology and Metabolism 15: 430-434.

Sharma P, Bhardwaj P, Singh R (2016) Administration of lactobacillus casei and bifidobacterium bifidum ameliorated hyperglycemia, dyslipidemia, and oxidative stress in diabetic rats. International Journal of Preventive Medicine 7: 102.

Fedorova IA, Danilenko VN (2014) Immunogenic properties of a probiotic component of the human gastrointestinal tract microbiota. Biology Bulletin Reviews 4: 457-466.

Jain S, Marotta F, Catanzaro R, Yadav H (2012) Immune system and gut flora interactions are important episodes in metabolic diseases. J Gastrointest Liver Dis 21: 347-348.

GASTROINTESTINAL KIT (2014) Immunogenic properties of the probiotic component of the microbiota of the human gastrointestinal tract. Advances in modern biology 134: 99-110.

Pandey R, Kumar N, Yadav M, Nagpal R, Jain S, et al. (2013) Anti-diabetic compounds and their patent information: An update. Recent patents on inflammation & allergy drug discovery 7: 35-48.

Aggarwal J, Swami G, Kumar M (2013) Probiotics and their effects on metabolic diseases: an update. J Clin Diagn Res 7: 173-177.

Nishant T, Bindu HK, Kumar SD, Kumar AR (2011) Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases. J Pharmacogenomics Pharmacoproteomics 2: 107.

Rouse R, Zhang L, Shea K, Zhou H, Xu L, et al. (2014) . Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet. PloS one 9: e109477.

Kanemaru K, Matsuyuki A, Nakamura Y, Fukami K (2015) Obesity exacerbates imiquimod‐induced psoriasis‐like epidermal hyperplasia and interleukin‐17 and interleukin‐22 production in mice. Experimental dermatology 24: 436-442.

Andersson SA, Olsson AH, Esguerra JL, Heimann E, Ladenvall C, et al. (2012) Reduced insulin secretion correlates with decreased expression of exocytotic genes in pancreatic islets from patients with type 2 diabetes. Molecular and cellular endocrinology 364: 36-45.

Hall E, Volkov P, Dayeh T, Bacos K, Rönn T, et al. (2014) Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC medicine 12: 103.

Money TT, Bousman CA (2013) Metabolomics of Psychotic Disorders. Metabolomics 3: 1-7.

Broderick G, Craddock TJ (2013) Systems biology of complex symptom profiles: capturing interactivity across behavior, brain and immune regulation. Brain, behavior, and immunity 29: 1-8.

Basavaraj S, Betageri GV (2014) Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges. Acta Pharmaceutica Sinica B 4: 3-17.

Relevant Topics

Google Scholar citation report
Citations: 895

Metabolomics:Open Access received 895 citations as per Google Scholar report

Metabolomics:Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward